The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: Protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial
Number of pages
SourceTrials, 22, (2021), article 856
Article / Letter to editor
Display more detailsDisplay less details
SW OZ BSI KLP
SubjectAll institutes and research themes of the Radboud University Medical Center; Experimental Psychopathology and Treatment; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences
Systemic sclerosis (scleroderma; SSc) is a rare autoimmune connective tissue disease. We completed an initial feasibility trial of an online self-administered version of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program using the cohort multiple randomized controlled trial (RCT) design. Due to low intervention offer uptake, we will conduct a new feasibility trial with progression to full-scale trial, using a two-arm parallel, partially nested RCT design. The SPIN-SELF Program has also been revised to include facilitator-led videoconference group sessions in addition to online material. We will test the group-based intervention delivery format, then evaluate the effect of the SPIN-SELF Program on disease management self-efficacy (primary) and patient activation, social appearance anxiety, and functional health outcomes (secondary).
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.